Ground Zero Pharmaceuticals Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Ground Zero Pharmaceuticals's estimated annual revenue is currently $2.3M per year.(i)
  • Ground Zero Pharmaceuticals's estimated revenue per employee is $155,000

Employee Data

  • Ground Zero Pharmaceuticals has 15 Employees.(i)
  • Ground Zero Pharmaceuticals grew their employee count by 0% last year.

Ground Zero Pharmaceuticals's People

NameTitleEmail/Phone
1
President & CEOReveal Email/Phone
2
SVP Finance/OperationsReveal Email/Phone
3
Sr. VP, Finance and OperationsReveal Email/Phone
4
Senior Regulatory Operations ManagerReveal Email/Phone
5
Regulatory Project ManagerReveal Email/Phone
6
Regulatory Project ManagerReveal Email/Phone
7
Sr. Mgr/Administrative AffairsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Ground Zero Pharmaceuticals?

Ground Zero Pharmaceuticals, Inc. (GZP) focuses on bringing medical product programs through the FDA regulatory process, from late discovery through final approval and postmarketing. GZP’s philosophy of doing “what is necessary and sufficient and no more” at each stage of development aids clients via clean, cost-effective, targeted and accelerated development plans. With emphasis on completing each portion of a product's lifecycle in a rapid and resource sparing manner, while maintaining acceptable quality for FDA review, GZP adds value to our client programs by enabling accomplishment of important milestones.

keywords:N/A

N/A

Total Funding

15

Number of Employees

$2.3M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M15N/AN/A
#2
$1.3M15N/AN/A
#3
$3.8M150%N/A
#4
$1.8M150%N/A
#5
$1.3M150%N/A